Evidence map›Paper›PMID 32676723›Full record

SynthesisDer Internist2020

[Gastroenteropancreatic neuroendocrine neoplasms-Heterogeneity, management and perspectives of treatment and research].

K Luley, J Gebauer, N Gebauer, L Tharun, I Buchmann, J Barkhausen, N von Bubnoff, K Lindner, T Keck, H Lehnert and 1 more

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Der Internist, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Gastroenteropancreatic neuroendocrine neoplasms: A clinical snapshot.World journal of gastrointestinal surgery · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

K LuleyKlinik für Hämatologie und Onkologie, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Deutschland. Kim.Luley@uksh.de.
J GebauerMed. Klinik 1, Abteilung für Endokrinologie, Diabetologie und Stoffwechselmedizin, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Deutschland. judith.gebauer@uksh.de.
N GebauerKlinik für Hämatologie und Onkologie, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Deutschland.
L TharunInstitut für Pathologie, Universität zu Lübeck, Lübeck, Deutschland.
I BuchmannKlinik für Radiologie und Nuklearmedizin, UKSH - Campus Lübeck, Lübeck, Deutschland.
J BarkhausenKlinik für Radiologie und Nuklearmedizin, UKSH - Campus Lübeck, Lübeck, Deutschland.
N von BubnoffKlinik für Hämatologie und Onkologie, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Deutschland.
K LindnerKlinik für Chirurgie, UKSH - Campus Lübeck, Lübeck, Deutschland.
T KeckKlinik für Chirurgie, UKSH - Campus Lübeck, Lübeck, Deutschland.
H LehnertUniversität Salzburg, Kapitelgasse 4, 5020, Salzburg, Österreich.
S M SchmidInstitut für Endokrinologie & Diabetes, Universität zu Lübeck, Lübeck, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The term neuroendocrine neoplasms (NEN) encompasses a molecularly and biologically very heterogeneous group of tumors, which have in common their origin in neuroendocrine cells. The also very heterogeneous subgroup of gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN) is the best classified and investigated group. This article provides a systematic review of the current classification, diagnostics and treatment options of GEP-NEN. In order to achieve a better overview, it was consciously decided not to use an approach based on the primary localization. Instead, a thematic organization according to classification, clinical phenotype, diagnostics and treatment was chosen.

Indexed as

Gastrointestinal NeoplasmsHumansIntestinal NeoplasmsNeuroendocrine TumorsPancreatic NeoplasmsStomach NeoplasmsClassificationDiagnostic imagingNeuroendocrine cellsNeuroendocrine neoplasmPhenotypeSomatostatin

Identifiers

PMID32676723

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.